We are live on ! Find out more
MIRM icon

Mirum Pharmaceuticals
MIRM

61 hedge funds and large institutions have $463M invested in Mirum Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 16

11% more capital invested

Capital invested by funds: $418M → $463M (+$45.3M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4.37% less ownership

Funds ownership: 81.21% → 76.83% (-4.4%)

15% less funds holding

Funds holding: 72 → 61 (-11)

58% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 19

Holders
61
Holders Change
-11
Holders Change %
-15.28%
% of All Funds
1.07%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
8
Increased
22
Reduced
16
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Axa
Axa
France
+$5.04M
2
BlackRock
BlackRock
New York
+$3.94M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$2.16M
4
Two Sigma Investments
Two Sigma Investments
New York
+$1.55M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.15M

Top Sellers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
-$4.79M
2
Millennium Management
Millennium Management
New York
-$3.71M
3
CH
CVI Holdings
Delaware
-$2.48M
4
MIM
Monashee Investment Management
Massachusetts
-$2.18M
5
MS
Maven Securities
Jersey
-$1.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Advisers
26
Two Sigma Advisers
New York
$1.37M +$883K +46,100 +200%
CIP
27
Chartwell Investment Partners
Pennsylvania
$1.3M -$67.5K -3,524 -5%
PAM
28
Panagora Asset Management
Massachusetts
$1.15M +$703K +36,724 +173%
AA
29
ALPS Advisors
Colorado
$1.09M +$175K +9,121 +20%
Invesco
30
Invesco
Georgia
$901K +$9.67K +505 +1%
GCP
31
GSA Capital Partners
United Kingdom
$691K +$252K +13,150 +61%
RJA
32
Raymond James & Associates
Florida
$671K +$10.4K +541 +2%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$534K -$12.7K -663 -2%
Jacobs Levy Equity Management
34
Jacobs Levy Equity Management
New Jersey
$463K +$447K +23,339 New
Los Angeles Capital Management
35
Los Angeles Capital Management
California
$382K +$369K +19,274 New
JP Morgan Chase
36
JP Morgan Chase
New York
$319K +$264K +13,774 +591%
AllianceBernstein
37
AllianceBernstein
Tennessee
$295K – – –
ECM
38
ExodusPoint Capital Management
New York
$289K +$279K +14,570 New
N
39
Nuveen
North Carolina
$284K -$201K -10,491 -42%
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$265K +$256K +13,353 New
VEA
41
Virtus ETF Advisers
New York
$248K +$4.27K +223 +2%
SO
42
STRS Ohio
Ohio
$243K – – –
PAG
43
Pinnacle Advisory Group
Maryland
$198K +$191K +10,000 New
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$172K +$14.9K +780 +10%
CSS
45
Cubist Systematic Strategies
Connecticut
$164K -$27.5K -1,434 -15%
Bank of America
46
Bank of America
North Carolina
$136K +$75.5K +3,944 +135%
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$107K – – –
Point72 Asset Management
48
Point72 Asset Management
Connecticut
$99K +$95.7K +5,000 New
Wells Fargo
49
Wells Fargo
California
$50K -$317K -16,538 -87%
UBS Group
50
UBS Group
Switzerland
$23K -$256K -13,393 -92%
1
2
3 4

MIRM Hedge Fund Activity: Q1 2021 in Review

61 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q1 2021, worth a combined $463M — up 11% from $418M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of MIRM and 8 opened new positions — a net loss of 11 holders — while 16 trimmed existing stakes and 22 added.

The largest buyer was Axa, adding an estimated $5.04M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $4.79M sold.

  • 61 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q1 2021, down from 72 in Q4 2020.
  • Funds reported $463M of Mirum Pharmaceuticals stock for Q1 2021, up 11% quarter-over-quarter.
  • 8 funds opened new Mirum Pharmaceuticals positions in Q1 2021 and 19 closed out, a net change of -11 holders.
  • The largest Mirum Pharmaceuticals buyer in Q1 2021 was Axa, an estimated $5.04M added.
  • The largest Mirum Pharmaceuticals seller in Q1 2021 was AIGH Capital Management, an estimated $4.79M sold.

Based on aggregated 13F filings for Q1 2021.